Loading…

Medical Research Finder

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Intestine GVHD

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Broad-spectrum antibiotics (ATB) such as carbapenems increase the risk of intestinal GVHD
Hayase et al. 2022 Cell 185(20): 3705-3719

The carbapenem meropenem exacerbates colonic GvHD in mice via expansion of Bacteroides thetaiotaomicron (BT)
Hayase et al. 2022 Cell 185(20): 3705-3719

Patients with Intestine GVHD refractory to treatment with glucocorticosteroids, c…

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation
Martin et al. 2012 Biol Blood Marrow Transplant 18(8): 1150-63
Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease
Hanash et al. 2012 Immunity 37: 339–350
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versushost disease
Hayase et al. 2022 Cell 185(20): 3705-3719
Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation
Castilla-Llorente et al. 2014 Bone Marrow Transplant 49(7): 966-71
Steroid-refractory acute GVHD: predictors and outcomes
Westin et al. 2011 Adv Hematol 2011: 601953
The primacy of the gastrointestinal tract as a target organ of acute graft-versus host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation
Hill & Ferrara 2020 Blood 95: 2754-2759
The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease
Bilinski et al. 2022 Biomedicines 10: 837
Review

2/26/2026